Skip to main content

Patient-Cantered Innovations in Ambulatory Care: Developing a Fixed-Dose Tablet to Enhance Adherence for Patients with Chronic Diseases.

Research Abstract

Objective

To improve medication adherence in patients with chronic diseases by developing a tablet formulation containing a combination of metformin, atorvastatin, aspirin, and enalapril maleate. Significance: Effectively managing chronic diseases often requires multiple medications, which can result in low patient adherence and suboptimal therapeutic outcomes. Developing a combination tablet is an effective modality to address this issue.

Methods

To test the patient perception, an online survey was distributed patients with chronic diseases. Based on the survey results, combination tablets were prepared by direct compression using a multifunctional excipient (PROSOLV® EASYtab). The compatibility between the drugs and excipients was studied using differential scanning calorimetry (DSC) and Fourier-transform infrared (FT-IR) spectroscopy. The tablets were evaluated for weight uniformity, friability, hardness, thickness, diameter, disintegration time, uniformity of drug content, and in vitro drug release.

Results

Most participants reported issues with non-adherence, but expressed a strong positive perception of combination tablets, particularly regarding their effectiveness in improving their condition. DSC and FT-IR studies confirmed the compatibility of the investigated drugs with each other and the used excipient. The tablets fulfilled the European Pharmacopeia 2014 specifications for the tested parameters. The release of all four drugs was fast and a cumulative percent drug release of approximately 50–85% was observed after 15 min.

Conclusions

These findings highlight the significant potential of the combination tablets as a single-dose delivery system, allowing the simultaneous administration of multiple medications for patients with chronic diseases, thereby enabling more effective and streamlined management.

Research Authors
Saleh F Alqifari, Hanan Alshareef, Heasham Tawfeek, Palanisamy Amirthalingam, Sadeem Alha rbi, Rahaf Alatawi, Hayaa Alahmari, Khulood Qasem, Ghareb Soliman.
Research Date
Research Department
Research Journal
Drug Development and Industrial Pharmacy
Research Pages
826-835
Research Publisher
Taylor and Francis
Research Vol
51
Research Website
https://doi.org/10.1080/03639045.2025.2513407
Research Year
2025

Training Day Activities at the Faculty of Pharmacy Within the framework of the training program for the initiative (A New Beginning for Quality Assurance and Accreditation in Education)

Under the patronage of His Excellency Professor Dr. Ahmed El-Menshawy, President of the University, and Professor Dr. Ahmed Abdel-Mawla, Vice President for Education and Student Affairs, and under the supervision of Professor Dr. Gihan Nabil Fatih, Dean of the Faculty, Professor Dr. Hassan Refaat Hassan, Vice Dean for Education and Student Affairs, Professor Dr. Ibrahim Mohamed Ismail, Director of the University's Quality Assurance and Accreditation Center, Professor Dr. Amani Mohamed Sherif, Deputy Director of the University's Quality Assurance and Accreditation Center and Coordinator of the Initiative, and Professor Dr. Gilan Abdel-Razek Abdel-Aleem, Professor in the Department of Industrial Pharmacy and Director of the Faculty's Quality Assurance and Accreditation Unit, the Faculty of Pharmacy, in cooperation with the University's Quality Assurance and Accreditation Center and the National Authority for Quality Assurance and Accreditation of Education (NAQAAE), organized the day's activities. A training session was held for pharmacy students as part of the "New Beginning for Quality Education and Accreditation" initiative. The lecture was delivered by Professor Dr. Gilan Abdel-Razek Abdel-Aleem, Professor in the Department of Industrial Pharmacy and Director of the Quality Assurance and Accreditation Unit at the Faculty. The session was attended by Professor Dr. Dina Fathallah Mohamed, Vice Dean for Graduate Studies and Research, along with faculty members, teaching assistants, and a large number of pharmacy students from various academic years. The initiative aims to raise student awareness of the importance of achieving quality education standards in building the Egyptian individual and preparing educated and aware graduates who are committed to their national identity, thus contributing to Egypt's Vision 2030 and the Sustainable Development Program in Education. The session took place on Monday, November 17, 2025, in the Faculty's auditorium.

 

news category
خبر عام

Potential Application of Origanum Majorana Stabilized Silver Nanoparticles for coating of Urinary catheter.

Research Abstract

Introduction: Urinary tract infections related to catheters are one of the most common urinary infections and can affect patient outcomes. Hence, coating urinary catheters is an important issue against several resistant bacterial pathogens that can form a resistant biofilm. This study examined the antibacterial and antibiofilm properties of the coated catheter with green silver nanoparticles (AgNPs) made from Origanum majorana.

Methods: Aloe Vera, Ocimum basilicum, Matricaria chamomilla, Foeniculum vulgare, Glycyrrhiza glabra, Origanum majorana, Urtica urens, Salvia Rosmarinus, and Salvia officinalis hydro-alcoholic extracts were prepared and tested for their antibacterial activities utilizing the agar well diffusion technique. Furthermore, O. majorana extract was tested against biofilm formation using a microtiter plate assay. UPLC-ESI-Q-TOF was used for the profiling and tentative identification of biological compounds in the O. majorana extract. O. majorana was used to prepare AgNPs-MARJ, which were characterized for their size, charge, and shape. Further, AgNPs-MARJ were used to coat two types of urinary catheters. The coated catheters were tested for their resistance to bacterial biofilm formation and compared with non-coated catheters.

Results and discussion: Initial antimicrobial screening tests showed that O. majorana extracts presented a significant (p<0.05; ANOVA/Tukey) antibacterial activity against the studied species of bacteria compared to the other plant extracts. O. majorana extract showed MIC value of 35.0 mg/mL for E. coli, Pseudomonas aeruginosa and K. pneumoniae and displayed the highest antibiofilm activity at 100 mg/mL. LC-MS analysis tentatively identified the presence of quinic acid and flavonoid-based constituents like apigenin which contribute to the antibiofilm activity. AgNPs-MARJ were efficiently prepared with a size and charge of 111.5 nm and -19.66 mV, respectively. The coated urinary catheters showed a significant (p<0.05) decrease in Pseudomonas aeruginosa biofilm formation compared to control non-coated catheters.

Conclusion: AgNPs-MARJ offer promising prospects for addressing biofilm-related challenges in urinary tract-related catheter infections.

Research Authors
Osamah Al Rugaie, Mustafa R Abdulbaqi, Amal W Danial, Hamdoon A Mohammed, Mansour Alsharidah, Hesham M Tawfeek, Ahmed A H Abdellatif
Research Date
Research Department
Research Pages
2941-2957
Research Publisher
Dove Press
Research Vol
15
Research Website
https://doi.org/10.2147/dddt.s512320
Research Year
2025

Announcement for students of the National University: The practical exam for the Medicinal Plants course (make-up) will be held on Thursday, December 4, 2025.

The practical make-up exam for the Medicinal Plants course for National University students will be held on Thursday, 4 December 2025, from 8:00 AM to 10:00 AM in the laboratories on the 3rd floor, Department of Pharmacognosy.

news category
إعلانات الطلاب

Announcement for students of the National University: The practical exam for the Matrouh Pharmacognosy -1 course will be held on Monday, December 8, 2025.

The practical make-up exam for the Medicinal Plants course for National University students will be held on Thursday, 4 December 2025, from 8:00 AM to 10:00 AM in the laboratories on the 3rd floor, Department of Pharmacognosy.

news category
إعلانات الطلاب

Antiparasitic efficacy of geraniol from Apiaceae family in scabies treatment

Research Abstract

Sarcoptic mange, commonly known as scabies, is a highly contagious skin condition caused by the
burrowing mite Sarcoptes scabiei (Astigmata: Sarcoptinae). This parasitic disease significantly impacts
livestock and human health, particularly in underserved regions. Current treatments rely on synthetic
acaricides like permethrin and ivermectin, which suffer from limitations such as toxicity, resistance
development, and environmental contamination. Essential oils from Apiaceae plants represent a
promising natural alternative. This study reviewed 122 volatile constituents from Apiaceae plants
and conducted comprehensive in silico analyses to identify potential antiparasitic agents. Geraniol
emerged as a potent acaricidal candidate due to its strong binding affinity to acetylcholinesterase
(AChE) (docking score: − 7.85 kcal/mol). In vitro testing revealed geraniol achieved a 100% mite
mortality rate at concentrations as low as 6.25% within 15 min (LT50 = 9.5 min). In vivo studies using
scabies-infected rabbits demonstrated that geraniol-treated animals exhibited complete clinical
recovery by two weeks post-treatment, with disappearance of crusts, itching, and skin thickening.
Histopathological examination showed near-complete skin regeneration with minimal inflammatory
infiltrates, in contrast to control groups which exhibited severe lesions and active mite presence.
Furthermore, geraniol-treated rabbits displayed new hair growth and improved general condition, with
no observed adverse effects. These findings highlight geraniol’s potential as a safe, effective, and ecofriendly
treatment for scabies, offering a 100% improvement in clinical and histological recovery within
two weeks. Further research should focus on optimizing delivery systems and evaluating its efficacy in
human clinical trials.

Research Authors
Iman S. A. Khallaf, Lourin G. Malak, Soad A. L. Bayoumi, Salwa F. Farag, Ahmed M. Sayed, Sara A. Mohamed, Asmaa A. E. Nasr, Radwa Y. Ibrahim, Eman Maher Zahran, Gerhard Bringmann & Usama Ramadan Abdelmohsen
Research Date
Research Department
Research Journal
Scientific Reports
Research Pages
16928
Research Publisher
Springer Nature
Research Vol
15
Research Website
https://doi.org/10.1038/s41598-025-97702-z
Research Year
2025

Announcement of Results and Appeals for Midterm Exam Grades for " Pharmacognosy 2" - Second Year Pharmacy Students, Private University, Academic Year 2025/2026

Click

?

" Pharmacognosy 2" Grades

 

 

Students wishing to appeal their midterm exam grade should register their names with the department secretary starting Tuesday, November 25, 2025.

 

The results of the appeals will be announced for students who have registered with the department secretary.

 

اعلان نتيجة و التماس درجة أعمال السنة لمقرر "عقاقير-2" – الفرقة الثانية فارم دى الجامعة الأهلية للعام الجامعى 2025/2026

news category
إعلانات الطلاب
Subscribe to